This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Eisai Dividend
Dividend criteriumcontroles 3/6
Belangrijke informatie
2.0%
Dividendrendement
142%
Uitbetalingsratio
| Gemiddelde opbrengst industrie | 2.2% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | n/a |
| Winst per aandeel | US$112.35 |
| Dividendrendementsvoorspelling | 2.1% |
Recente dividendupdates
Recent updates
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: ESAL.Y's dividends per share have been stable in the past 10 years.
Groeiend dividend: ESAL.Y's dividend payments have increased over the past 10 years.
Dividendrendement versus markt
| Eisai Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (ESAL.Y) | 2.0% |
| Markt onderkant 25% (US) | 1.5% |
| Markt Top 25% (US) | 4.5% |
| Gemiddelde industrie (Pharmaceuticals) | 2.2% |
| Analist prognose (ESAL.Y) (tot 3 jaar) | 2.1% |
Opmerkelijk dividend: ESAL.Y's dividend (2%) is higher than the bottom 25% of dividend payers in the US market (1.49%).
Hoog dividend: ESAL.Y's dividend (2%) is low compared to the top 25% of dividend payers in the US market (4.24%).
Winstuitkering aan aandeelhouders
Verdiendekking: With its high payout ratio (142.3%), ESAL.Y's dividend payments are not well covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: ESAL.Y is paying a dividend but the company has no free cash flows.